Physician

Tahsin Choudhury, M.D.

According to 2025 Medicare claims, Tahsin Choudhury, M.D. (NPI: 1467713685) practices ophthalmology in the Syracuse, NY market, with the plurality of this provider's patient population coming from Onondaga, NY. This provider's primary affiliated billing organization is RETINA-VITREOUS SURGEONS OF CENTRAL NEW YORK, PC (NPI: 1124012737; TIN: 16-0993668) and primary practice location at 13088-6655.

Choudhury's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,149 traditional Medicare patients, billed 42,232 HCPCS/CPT codes, and received $3,462,015 in Medicare payments. The top billing code was J0178 (Injection, aflibercept, 1 mg). Part D data shows 747 prescription claims across 248 beneficiaries totaling $19,506 in drug costs, led by Prednisolone Acetate (Prednisolone Acetate). Open Payments data shows 8 records totaling $244. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $177,844 to $3,462,015. Similarly, Part D prescription costs have moved from a lower plateau to a higher plateau, from $16,422 to $19,506. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	N/R	N/R	N/R
2016	328	2,270	$177,844
2017	271	1,642	$128,088
2018	535	3,783	$917,945
2019	775	10,158	$2,510,706
2020	752	10,285	$2,897,387
2021	913	11,220	$3,011,259
2022	1,021	14,331	$3,403,954
2023	1,058	23,887	$3,450,644
2024	1,149	42,232	$3,462,015

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	97	348	$16,422
2016	42	137	$13,943
2017	28	101	$14,049
2018	94	244	$12,241
2019	140	418	$14,531
2020	143	428	$19,229
2021	220	645	$34,082
2022	213	687	$27,432
2023	270	693	$29,934
2024	248	747	$19,506

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
J0178	Injection, aflibercept, 1 mg	330	2,750	$656
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	292	303	$97
67028	Injection of drug into eye	467	2,192	$86
92014	Established patient complete exam of visual system	462	531	$86
92134	Imaging of retina	1,029	2,994	$30

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Prednisolone Acetate	Prednisolone Acetate	230	8,695	$8,792
Ketorolac Tromethamine	Ketorolac Tromethamine	73	2,338	$1,038
Atropine Sulfate	Atropine Sulfate	16	866	$838
Dorzolamide-Timolol	Dorzolamide Hcl/Timolol Maleat	56	4,315	$730
Tobramycin	Tobramycin	138	3,500	$662

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	8	$244	Genentech USA, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Tahsin Choudhury, M.D.?

Tedicare shows public-source Medicare data for Tahsin Choudhury, M.D. (NPI 1467713685), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Tahsin Choudhury, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Tahsin Choudhury, M.D.?

Tahsin Choudhury, M.D. is linked to RETINA-VITREOUS SURGEONS OF CENTRAL NEW YORK, PC (billing NPI 1124012737) in the available physician profile data.

Does Tahsin Choudhury, M.D. have Open Payments data?

Tahsin Choudhury, M.D. has 8 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.